Bio Impact Capital LLC Reata Pharmaceuticals Inc Transaction History

Bio Impact Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $4.56 Million - $6.07 Million	57,604 Added 32.57%	234,478 $23.9 Million
Q1 2023 May 12, 2023	SELL	$30.85 - $93.17 $533,920 - $1.61 Million	-17,307 Reduced 8.91%	176,874 $16.1 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $334,974 - $636,829	15,123 Added 8.45%	194,181 $7.38 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $18,284 - $34,373	-942 Reduced 0.52%	179,058 $4.5 Million
Q1 2022 May 13, 2022	BUY	$24.12 - $39.6 $4.34 Million - $7.13 Million	180,000 New	180,000 $5.9 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.